14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Tuesday, 7th May 2024 CPRX stock ended at $15.14. This is 1.00% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 2.97% from a day low at $14.82 to a day high of $15.26.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
Mar 03, 2021 $3.94 $3.96 $3.67 $3.68 1 745 935
Mar 02, 2021 $4.02 $4.05 $3.91 $3.96 1 543 167
Mar 01, 2021 $4.00 $4.02 $3.91 $4.00 793 255
Feb 26, 2021 $3.93 $4.04 $3.83 $3.89 1 241 784
Feb 25, 2021 $4.06 $4.18 $3.88 $3.90 1 506 200
Feb 24, 2021 $4.05 $4.10 $4.00 $4.03 993 325
Feb 23, 2021 $4.16 $4.20 $3.94 $4.02 2 125 342
Feb 22, 2021 $4.32 $4.40 $4.22 $4.28 1 187 861
Feb 19, 2021 $4.39 $4.50 $4.34 $4.34 1 135 385
Feb 18, 2021 $4.22 $4.45 $4.22 $4.31 1 574 493
Feb 17, 2021 $4.17 $4.32 $4.05 $4.28 1 807 473
Feb 16, 2021 $4.20 $4.27 $4.12 $4.12 1 558 777
Feb 12, 2021 $4.33 $4.33 $4.18 $4.20 1 463 375
Feb 11, 2021 $4.52 $4.60 $4.28 $4.33 1 894 359
Feb 10, 2021 $4.81 $4.82 $4.46 $4.57 2 262 619
Feb 09, 2021 $4.58 $4.70 $4.48 $4.60 1 875 811
Feb 08, 2021 $4.42 $4.60 $4.31 $4.54 2 064 290
Feb 05, 2021 $4.31 $4.40 $4.20 $4.37 2 414 030
Feb 04, 2021 $4.55 $4.61 $4.19 $4.23 2 322 449
Feb 03, 2021 $4.28 $4.68 $4.26 $4.47 3 553 679
Feb 02, 2021 $4.00 $4.23 $3.94 $4.23 3 386 161
Feb 01, 2021 $3.70 $3.90 $3.62 $3.88 2 016 445
Jan 29, 2021 $3.60 $3.70 $3.57 $3.64 2 085 347
Jan 28, 2021 $3.68 $3.75 $3.59 $3.60 1 407 351
Jan 27, 2021 $3.62 $3.72 $3.54 $3.63 2 436 786
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT